A Subsidiary of Beijing No.1 Biochemical Pharmaceutical Company
About First Biotech (Australia)
First Biotech (Australia) was established in 2017, as part of Beijing No.1 Biochemical Pharmaceutical Company’s global strategy to expand its global footprint. First Biotech (Australia) aims to work with major universities and industry partners in Australia to establish new research and development projects, providing collaborative opportunities between China and Australia.
First Biotech (Australia) is based in Port Melbourne, Victoria. It joins a global sales network, cultivated by Beijing No.1 Pharmaceutical Company since 1958. The network spans more than 8,000 hospitals, as well as 29 provinces, municipalities, and autonomous regions within China.
Its medicines are widely recognised by both doctors and patients.
Backed by decades of biochemical pharmaceutical and R&D experience through Beijing No.1 Biochemical Pharmaceutical Company, First Biotech (Australia) will enhance biochemical pharmaceutical development in Australia.
First Biotech operates in conjunction with:
The Institute of Process Engineering, Chinese Academy of Sciences
Department of Immunology, Peking University
Chinese Academy of Medical Sciences
Capital Medical University